Key facts
- This page summarizes Jill M. Quigley's Form 4 filing for Chemomab Therapeutics Ltd. (CMMB).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Jun 2023, 06:03.
Jill M. Quigley - 16 Jun 2023 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)
- Reporting relationship
- Director
- Issuer ticker
- CMMB
- Reported as of
- 16 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jun 2023, 06:03:03 UTC
- Prior SEC filing
- 14 Jun 2023
- Next SEC filing
- 17 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David S. Glatt, Attorney-in-Fact for Jill M. Quigley
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jill M. Quigley filed Form 4 for Chemomab Therapeutics Ltd. (CMMB) on 20 Jun 2023.
Change
- Previous filing in this sequence was filed on 14 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMMB
transaction
Derivative
Option to Purchase American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +6,857
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 20,497
- Date
- 16 Jun 2023
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 6,857
- Exercise price
- $1.71
- Footnotes
- F1, F2
CMMB
transaction
Derivative
Option to Purchase American Depositary Shares
Award
- Transaction value
- $0
- Shares
- +13,640
- Change %
- Price
- $0.000000
- Shares after
- 13,640
- Date
- 16 Jun 2022
- Ownership
- Direct
- Underlying class
- American Depositary Shares
- Underlying amount
- 13,640
- Exercise price
- $3.25
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
Footnote F2
These options shall vest and become exercisable in full at the end of the 12 month period commencing on June 16, 2023 subject to the Reporting Person's continued service.
Footnote F3
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this form 4 for informational purposes only.
Footnote F4
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on June 16, 2022, subject to the Reporting Person's continued service.